 Home > Active Ingredient News > Drugs Articles > Pfizer Ogaituzumab for Injection Approved in China to Treat Leukemia

Pfizer Ogaituzumab for Injection Approved in China to Treat Leukemia

 Last Update: 2021-12-24
 Source: Internet
 Author: User

Tags

metoclopramide drug class

surface drug testing kits

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

According to the latest announcement by the National Food and Drug Administration (NMPA), Pfizer's application for Ogaituzumab for injection (previous name: Ogaituzumab for injection) has been approved in China

Screenshot source: NMPA official website

Ogaituzumab (inotuzumab ozogamicin) is an innovative ADC developed by Pfizer.

In August 2017, Ogaituzumab was approved by the U.

In China, the marketing application of Ogaituzumab was accepted by the Center for Drug Evaluation (CDE) of the National Medical Products Administration of China in January 2020, and was included in priority review due to "innovative drugs with obvious therapeutic advantages"

According to the clinical data when Ogaituzumab was approved for this indication in the United States, in the treatment of adult relapsed or refractory B-cell precursor acute lymphoblastic leukemia, compared with chemotherapy group, Ogaituzumab The monoclonal antibody group can significantly improve the patient's complete response rate (CR) and prolong the patient's median overall survival

Acute lymphocytic leukemia is an extremely aggressive leukemia with a very poor prognosis in adult patients

Reference materials:

[1] Information to be obtained for the drug approval certificate issued by the State Drug Administration of China on December 22.

[2] Heavy! The first CD22 antibody drug conjugate received accelerated approval today.
Retrieved Aug 18, 2021, from https://mp.
weixin.
qq.
com/s?__biz=MzAwMDA5NTIxNQ==&mid=2649964311&idx=2&sn=cd8e6a8e97effefcea8966cd758411e76d3effefcea8966cd758411e76d3effefcea8966cd758411e76d3effefcea8966cd758411e76d59cfccded3a0&fc57c57cfc57cfc57d89449m

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

N-Methyl-L-alanine3913-67-5

CAS No.: 3913-67-5

Industrial Grade

$1-1.04/KG FOB

High Purity 99% PEG MGF CAS 108174-48-7 Customized Peptides from China OUDA

CAS No.: 108174-48-7

Pharmacy Grade

$2-2.6/G FOB

Wholesales Purity 99 Peptides Powder Sema Tirz Retatrutide 5mg/10mg/15mg to Door From China

CAS No.: 2023788-19-2

Pharmacy Grade

$150-180/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.